SutroVax Announces Appointment of Distinguished Conjugate Vaccine Developer Dr. Bruce Forrest to Scientific Advisory Board by longitudeadmin | Jan 6, 2016 | Portfolio News
Practice Fusion Accelerates Revenue Growth and Adds 5,000 New Active Practices in 2015 by longitudeadmin | Jan 4, 2016 | Portfolio News
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer by longitudeadmin | Dec 17, 2015 | Portfolio NewsAimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Collegium Announces Publication of Nasal Human Abuse Potential Study in American Academy of Pain Medicine by longitudeadmin | Dec 16, 2015 | Portfolio News
Practice Fusion Expands Executive Team with Hiring of New Chief Operating Officer; Promotes New Senior VP of Product Management by longitudeadmin | Dec 16, 2015 | Portfolio News
